IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,876,104 | +147.9% | 5,906,836 | +283.6% | 0.06% | +129.2% |
| Q2 2023 | $10,840,241 | -35.1% | 1,539,807 | -43.7% | 0.02% | -42.9% |
| Q1 2023 | $16,714,430 | +1855.6% | 2,735,586 | +1945.2% | 0.04% | +2000.0% |
| Q4 2022 | $854,688 | -96.1% | 133,754 | -94.2% | 0.00% | -97.0% |
| Q3 2022 | $21,924,000 | +11.6% | 2,288,532 | +28.6% | 0.07% | +4.7% |
| Q2 2022 | $19,644,000 | -39.0% | 1,779,389 | -8.0% | 0.06% | -36.6% |
| Q1 2022 | $32,201,000 | +18.2% | 1,934,024 | +35.5% | 0.10% | +8.6% |
| Q4 2021 | $27,239,000 | -29.6% | 1,426,835 | -9.0% | 0.09% | -42.2% |
| Q3 2021 | $38,678,000 | +120.5% | 1,568,460 | +132.7% | 0.16% | +94.0% |
| Q2 2021 | $17,540,000 | +231.1% | 674,124 | +302.9% | 0.08% | +219.2% |
| Q1 2021 | $5,297,000 | +73.0% | 167,312 | +153.5% | 0.03% | +52.9% |
| Q4 2020 | $3,062,000 | -94.0% | 66,000 | -95.8% | 0.02% | -95.5% |
| Q3 2020 | $51,449,000 | +12387.6% | 1,562,864 | +10319.1% | 0.38% | +9325.0% |
| Q2 2020 | $412,000 | -97.5% | 15,000 | -97.3% | 0.00% | -98.0% |
| Q1 2020 | $16,793,000 | +4551.8% | 560,979 | +1375.8% | 0.20% | +9850.0% |
| Q1 2019 | $361,000 | -20.1% | 38,011 | -25.6% | 0.00% | -33.3% |
| Q4 2018 | $452,000 | -72.2% | 51,115 | -64.6% | 0.00% | -57.1% |
| Q3 2018 | $1,623,000 | +261.5% | 144,287 | +311.3% | 0.01% | +250.0% |
| Q2 2018 | $449,000 | – | 35,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |